Masimo Received the US FDA's 510(k) Approval for the Masimo W1 Medical Watch
Shots:
- The US FDA cleared Masimo W1 Medical Watch for OTC & prescription use in hospitals, clinics, long-term care facilities & in the home, which provides continuous real-time oxygen saturation (SpO2) and pulse rate (PR)
- The wearable device integrates an optical sensor and ECG electrode pads to detect physiological signals. These signals are processed using Masimo's proprietary algorithms to output SpO2, PR, Pi, & HR
- The Masimo MW-1 module provides continuous data, displayed in real-time on the Masimo W1 watch touchscreen. The SpO2 and PR values are highlighted in red when they fall outside their normal ranges, making it easier to identify low SpO2 and high or low PR
Ref: Businesswire | Image: Masimo
Related News:- GE HealthCare and Masimo Enter into a Collaboration Agreement to Combine Masimo SET Pulse Oximetry with the Portrait Mobile Platform
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.
